Mobile Health and COVID-19
Mobile Health to Monitor Risk for COVID-19 and Improve Mental Health During the Pandemic
1 other identifier
interventional
822
1 country
2
Brief Summary
The proposed research focuses on evaluating the mobile application, Easing Anxiety Sensitivity for Everyone (EASE), to improve overall public health that concerns risks and mental health status during the coronavirus disease of 2019 (COVID-19) pandemic and to minimize the existing health disparities among Black, Hispanic and Latino, and American Indian (BLAI) individuals during this time. EASE provides COVID-19 symptom monitoring, exposure management skills, and psychoeducation on stress and it's impact on infection and disease susceptibility. This study aims to compare the effect of EASE to an empirical measurement of standard-of-care digital intervention and to identify the effective mechanisms in EASE.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2021
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 2, 2021
CompletedFirst Posted
Study publicly available on registry
October 12, 2021
CompletedStudy Start
First participant enrolled
December 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 26, 2024
CompletedResults Posted
Study results publicly available
September 24, 2025
CompletedSeptember 24, 2025
September 1, 2025
2.1 years
October 2, 2021
July 7, 2025
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Everyday Impairment
Changes in reported anxiety and depression related impairment experienced in major life sectors (work performance, household maintenance, social interactions, relationships) as measured by study developed items from Baseline to follow-up assessments. This measure was created by the study team and was 4 items rated from 1 (Strongly disagree) to 5 (Strongly agree). The scale is summed for a total score with ranges from 4 to 25, with higher scores indicating greater everyday impairment.
From Baseline to 6-Months
Anxiety
Change from Screener in anxiety on the 5-item Overall Anxiety Severity and Impairment Scale (OASIS) at follow-up appointments. The OASIS is made up of 5 items rated on a scale from 0 to 4. The OASIS is summed for a total score, with a range from 0 to 25, with higher scores indicating higher anxiety severity and impairment.
From Screener to 6-Months
Depression
Change from Screener in depression on the 5-item Overall Depression Severity and Impairment Scale (ODSIS) at subsequent follow-up appointments. The ODSIS is made up of 5 items rated on a scale from 0 to 4. The ODSIS is summed for a total score, with a range from 0 to 25, with higher scores indicating higher depression severity and impairment.
From Screener to 6-Month
Secondary Outcomes (8)
Perceived Discrimination
From Baseline to end of study, up to 6 months.
Racial Bias/Discrimination
From Baseline to end of study, up to 6 months.
Perceive Social Support
From Baseline to end of study, up to 6 months.
Subjective Social Status
From Baseline to end of study, up to 6 months.
Anxiety Sensitivity
Baseline to end of study, up to 6 months.
- +3 more secondary outcomes
Study Arms (2)
EASE App
EXPERIMENTALEASE is a intervention designed to address anxiety and depression symptoms in its users through the use of educational videos, tailored messages, and interoceptive exercises designed to help the user overcome negative feelings of stress.
INSIGHT (Control) APP
OTHERThe Insight app provides users with educational videos on mindfulness and meditation techniques.
Interventions
EASE is a mobile intervention designed to reduce ongoing mental health concerns among BLAI individuals with elevated anxiety and/or depressive symptoms by targeting anxiety sensitivity. The EASE app employs a variety of features to educate its users on how to deal with increased levels of stress, anxiety, and depression, and train users on how to better cope with the negative feelings of stress. The app contains a series of on-demand features, including a coping toolkit, stress management trainings, and a series of educational videos designed to teach participants how to better deal with stress. EASE also utilizes Ecological Momentary Assessments (EMAs) to gather information, and provide personalized messages to users in real time. Finally, EASE is outfitted with COVID-19 related elements, including a symptoms tracker (which participants can use to report symptoms of COVID-19 they may be experiencing), and a collection of COVID-19 related food, housing, and job placement resources.
A standard of care control intervention was developed using the INSIGHT platform. This app contains a library of educational videos that cover topics such as meditation and mindfulness, as well as general stress reduction techniques. Additionally, participants have access to a "Report Distress" feature that enables them to report moments when they are feeling high levels of stress. Finally, participants will be able to report any COVID-19 related symptoms they experience using a COVID-19 symptom tracker feature. Participants assigned to this condition will received 2 daily EMAs, during which they will be prompted to watch one of the aforementioned educational videos.
Eligibility Criteria
You may qualify if:
- ≥ 18 years of age
- Self-identify as Black, Latinx, American Indian, or NLW
- Clinically significant anxiety and/or depressive symptoms as evinced by a score of 8 or higher on the Overall Anxiety Severity and Impairment Scale (OASIS) and/or Overall Depression Severity and Impairment Scale (ODSIS)
- Reside in Texas or Oklahoma
- Willing/able to complete EMAs on study provided or personal smartphone for 6-month study period
- Willing and able to complete the 3- and 6-month follow-up assessments via the app and over the phone (i.e., qualitative interview)
- Score ≥ 4 on the REALM-Short Form indicating \> 6th grade English literacy level (needed to complete EMAs)
You may not qualify if:
- Not fluent in English
- Lifetime or significant cognitive impairment
- Identifying as a race/ethnicity for which the corresponding study cell has been filled
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Houstonlead
- University of Oklahomacollaborator
- Oklahoma State Universitycollaborator
Study Sites (2)
TSET Health Promotion Research Center
Oklahoma City, Oklahoma, 73104, United States
RESTORE Laboratory: Research on Emotion, Substance Use Treatment Outcomes, Rehabilitation, and Empowerment
Houston, Texas, 77204, United States
Related Publications (2)
Rhudy JL, Kell PA, Shadlow JO, Lowe TS, Stephens LD, Zvolensky MJ, Garey L, Kendzor DE, Businelle MS. Assessing racial/ethnic differences in sleep-pain relationships using intensive longitudinal modeling among Native Americans. Sleep. 2026 Jan 13;49(1):zsaf216. doi: 10.1093/sleep/zsaf216.
PMID: 40709831DERIVEDGarey L, Zvolensky MJ, Gallagher MW, Vujanovic A, Kendzor DE, Stephens L, Cheney MK, Cole AB, Kezbers K, Matoska CT, Robison J, Montgomery A, Zappi CV, Businelle MS. A Smartphone-Based Intervention for Anxiety and Depression in Racially and Ethnically Diverse Adults (EASE): Protocol for a Randomized Controlled Trial. JMIR Res Protoc. 2022 Dec 5;11(12):e40713. doi: 10.2196/40713.
PMID: 36409958DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Michael Zvolensky, Ph.D.
- Organization
- University of Houston
Study Officials
- PRINCIPAL INVESTIGATOR
Michael Zvolensky, Ph.D.
University of Houston
- PRINCIPAL INVESTIGATOR
Michael Businelle, Ph.D.
University of Oklahoma Health Sciences
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Hugh Roy and Lillie Cranz Cullen Distinguished University Professor
Study Record Dates
First Submitted
October 2, 2021
First Posted
October 12, 2021
Study Start
December 20, 2021
Primary Completion
January 26, 2024
Study Completion
January 26, 2024
Last Updated
September 24, 2025
Results First Posted
September 24, 2025
Record last verified: 2025-09